Robotic-assisted resection for beyond TME rectal cancer: a novel classification and analysis from a specialized center

被引:0
作者
G. N. Piozzi
T-H. Lee
J-M. Kwak
J. Kim
S-H. Kim
机构
[1] Fondazione IRCCS Istituto Nazionale Dei Tumori,Colorectal Surgery Unit, Department of Surgery
[2] Korea University College of Medicine,Division of Colorectal Surgery, Department of Surgery, Korea University Anam Hospital
来源
Updates in Surgery | 2021年 / 73卷
关键词
Beyond total mesorectal excision; Robotic surgery; Rectal cancer; Intersphincteric resection; Pelvic lateral lymph node dissection; Multivisceral resection;
D O I
暂无
中图分类号
学科分类号
摘要
Locally advanced rectal cancer often requires an extended resection beyond the total mesorectal excision plane (bTME) to obtain clear resection margins. We classified three types of bTME rectal cancer following local disease diffusion: radial (adjacent pelvic organs), lateral (pelvic lateral lymph nodes) and longitudinal (below 3.5 cm from the anal verge, submitted to intersphincteric resection). The primary aim of this study was to evaluate the application of robotic surgery to the three types of bTME regarding the short and long-term oncological outcomes. Secondary aim was to identify survival prognostic factors for bTME rectal cancers. A total of 137 patients who underwent robotic-assisted bTME procedures between 2008 and 2018 were extracted from a prospectively collected database. Patient-related, operative and pathological factors were assessed. Morbidity was moderately high with 66% of patients reporting postoperative complications. Median follow up was 47 months (IQR, 31.5–66.5). Local recurrence rate was 15.3% with a statistical difference between the three types of bTME (p = 0.041). Disease progression/distant metastasis rate was 33.6%. Overall survival was significantly different (p = 0.023) with 1- and 3-years rates of: 77.8% and 55.0% (radial; n = 19); 96.6% and 84.8% (lateral; n = 30); 97.7% and 86.9% (longitudinal; n = 88). No statistical difference was observed for disease-free survival (p = 0.897). Local recurrence-free survival was significantly different between the groups (p = 0.031). Multivariate analysis showed that (y)pT (p = 0.028; HR (95% CI) 5.133 (1.192–22.097)), (y)pN (p = 0.014; HR (95% CI) 2.835 (1.240–6.482)) and type of bTME were associated to OS whilst (y)pT (p = 0.072) and type of bTME were not associated to LRFS.
引用
收藏
页码:1103 / 1114
页数:11
相关论文
共 101 条
[1]  
Heald RJ(1982)The mesorectum in rectal cancer surgery–the clue to pelvic recurrence? Br J Surg 69 613-616
[2]  
Husband EM(1998)Rectal cancer: the Basingstoke experience of total mesorectal excision, 1978–1997 Arch Surg 133 894-899
[3]  
Ryall RD(2011)Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial Lancet Oncol 12 575-582
[4]  
Heald RJ(2013)Consensus statement on the multidisciplinary management of patients with recurrent and primary rectal cancer beyond total mesorectal excision planes Br J Surg 100 1009-1014
[5]  
Moran BJ(2002)Multivisceral resection for locally advanced primary colon and rectal cancer: an analysis of prognostic factors in 201 patients Ann Surg 235 217-225
[6]  
Ryall RD(2008)Prognostic factors after preoperative irradiation and surgery for locally advanced rectal cancer Eur J Surg Oncol 34 410-417
[7]  
van Gijn W(2012)Multivisceral resections for rectal cancer Br J Surg 99 1137-1143
[8]  
Marijnen CA(2015)Survival after pelvic exenteration for T4 rectal cancer Br J Surg 102 125-131
[9]  
Nagtegaal ID(2014)First report: Robotic pelvic exenteration for locally advanced rectal cancer Colorectal Dis 16 O9-14
[10]  
Beyond TMEC(2017)Robotic-assisted multivisceral resection for rectal cancer: short-term outcomes at a single center Tech Coloproctol 21 879-886